 |
|
An Observational Study of Cognitive Impairment in Amyotrophic Lateral Sclerosis
Gregory A. Rippon, MD, MS;
Nikolaos Scarmeas, MD;
Paul H. Gordon, MD;
Peregrine L. Murphy, PhD;
Steven M. Albert, PhD;
Hiroshi Mitsumoto, MD;
Karen Marder, MD, MPH;
Lewis P. Rowland, MD;
Yaakov Stern, PhD
Arch Neurol. 2006;63:345-352.
Background Cognitive impairment is increasingly recognized in patients with amyotrophic lateral sclerosis (ALS). Clinical and pathologic features overlap in frontotemporal lobar dementia and ALS. Demographics, respiratory status, bulbar site of onset, and disease severity are potential risk factors for cognitive impairment in ALS.
Objectives To further delineate the frequency, nature, and implications of cognitive impairment in ALS and to assess previously identified risk factors.
Design Case-control and retrospective cohort study.
Setting Academic referral center.
Participants Forty consecutive patients with ALS underwent baseline neurologic and neuropsychologic examinations. Cognitive test performance was compared in patients with ALS and matched controls. An exploratory analysis of the relationship between cognitive performance and ALS survival was performed.
Main Outcome Measures Neuropsychologic test performance, ALS severity, and survival.
Results Twelve patients (30%) showed evidence of cognitive impairment, including 9 (23%) who met the neuropsychologic criteria for dementia. No statistically significant differences were found between demented and nondemented ALS groups regarding demographics, family history, site of onset, bulbar dysfunction, or ALS severity. Only 1 patient with dementia had bulbar-onset disease. An association was observed between increasing ALS severity and declining verbal fluency performance. Demented patients with ALS showed predominant impairment in free recall, executive function, and naming, with relative preservation of attention, psychomotor speed, and visuospatial function. No association was observed between cognition and survival, controlling for ALS severity.
Conclusions Nearly a third of the patients with ALS showed evidence of cognitive impairment in a pattern consistent with frontotemporal lobar dementia. Cognitive performance was not related to site of onset or survival.
Author Affiliations: Department of Neurology (Drs Rippon, Scarmeas, Gordon, Mitsumoto, Marder, and Rowland), Gertrude H. Sergievsky Center (Drs Rippon, Scarmeas, Murphy, Albert, Marder, and Stern), Taub Institute for Research on Alzheimer's Disease and the Aging Brain (Drs Rippon, Scarmeas, Murphy, Albert, Marder, and Stern), Eleanor and Lou Gehrig MDA/ALS Research Center (Drs Gordon, Albert, Mitsumoto, and Rowland), and Department of Psychiatry (Drs Marder and Stern), Columbia University College of Physicians and Surgeons, New York, NY.
RELATED ARTICLE
ALS—Not What We Thought
Michael J. Strong
Arch Neurol. 2006;63(3):319-320.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Application of a Joint Multivariate Longitudinal-Survival Analysis to Examine the Terminal Decline Hypothesis in the Swiss Interdisciplinary Longitudinal Study on the Oldest Old
Ghisletta
J. Gerontol. B Psychol. Sci. Soc. Sci. 2008;63:P185-P192.
ABSTRACT
| FULL TEXT
Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS
Hammad et al.
Neurology 2007;69:2236-2242.
ABSTRACT
| FULL TEXT
Cognition and Amyotrophic Lateral Sclerosis (ALS)
Irwin et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;22:300-312.
ABSTRACT
ALS--Not What We Thought.
Strong
Arch Neurol 2006;63:319-320.
FULL TEXT
|
